Blue Trust’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$955 Hold
19
– – ﹤0.01% 2179
2026
Q2
$1.28K Hold
19
– – ﹤0.01% 2258
2026
Q1
$1.05K Hold
19
– – ﹤0.01% 2250
2025
Q4
$921 Hold
19
– – ﹤0.01% 2301
2025
Q3
$582 Hold
19
– – ﹤0.01% 2401
2025
Q2
$422 Hold
19
– – ﹤0.01% 2331
2025
Q1
$353 Buy
+19
New +$317 ﹤0.01% 2390
2023
Q2
– Sell
-19
Closed -$1K – 2009
2023
Q1
$1K Hold
19
– – ﹤0.01% 2095
2022
Q4
$0 Hold
19
– – ﹤0.01% 2210
2022
Q3
$0 Hold
19
– – ﹤0.01% 2071
2022
Q2
$0 Buy
+19
New +$421 ﹤0.01% 1883

Other funds holding ANAB

Blue Trust's ANAB Position: Q3 2026 in Review

Blue Trust held its AnaptysBio (ANAB) position steady in Q3 2026 at 19 shares worth $955. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Blue Trust first reported a position in ANAB in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.28K in Q2 2026. 165 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Blue Trust held 19 shares of AnaptysBio worth $955 as of Q3 2026.
  • Blue Trust left its AnaptysBio share count unchanged in Q3 2026.
  • AnaptysBio made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2179 holding.
  • Blue Trust first reported a position in AnaptysBio in Q2 2022 and has held it in 11 quarters since.
  • Blue Trust's AnaptysBio position peaked at $1.28K in Q2 2026.
  • 165 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.